Chemed Corporation to Present at the BofA Securities 2025 Virtual Home Care Conference
Rhea-AI Summary
Chemed Corporation (NYSE:CHE) will present at the BofA Securities 2025 Virtual Home Care Conference on Tuesday, December 9, 2025 at 1:20 PM ET. The presentation will be webcast live and presentation materials will be available on Chemed's investor relations website at www.chemed.com.
The webcast replay will be posted within 24 hours of the live presentation and will remain accessible for 90 days. Chemed operates two subsidiaries: VITAS Healthcare (end-of-life hospice services) and Roto-Rooter (plumbing and drain cleaning services). The company cautions that any forward-looking statements are subject to risks and may differ materially.
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, CHE declined 1.52%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
CHE was up 1.18% while key peers showed mixed moves (e.g., DVA +0.8%, SGRY -2.66%), indicating stock-specific rather than broad sector momentum.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Dec 04 | Investor conference | Neutral | -1.5% | Announcement of BofA virtual home care conference presentation and webcast access. |
| Nov 25 | Brand marketing | Neutral | +1.0% | VITAS video release highlighting hospice-at-home caregiver experience and support. |
| Nov 07 | Dividend declaration | Positive | +0.9% | Quarterly dividend of $0.60 per share, 218th consecutive dividend. |
| Nov 04 | Investor conference | Neutral | -0.4% | UBS 2025 Global Healthcare Conference presentation with webcast and materials. |
| Oct 28 | Earnings results | Neutral | +0.5% | Q3 2025 revenue and EPS update for VITAS and Roto-Rooter segments. |
Recent CHE news, including conferences, a dividend, and earnings, has typically led to modest, directionally aligned price moves within a narrow +/-1.5% range over the next day.
Over the last several months, Chemed has combined routine investor outreach with steady capital returns and mixed operating trends. Q3 2025 results on Oct 28 showed revenue of $624.9M with diluted EPS of $4.46, and the stock rose 0.49%. A quarterly dividend of $0.60 per share announced on Nov 7 coincided with a 0.93% gain. Conference appearances on Nov 11 and Dec 9 and brand-focused VITAS content have generally produced small, aligned price reactions.
Market Pulse Summary
This announcement highlights Chemed’s participation in the BofA Securities 2025 Virtual Home Care Conference on December 9, 2025, with a webcast at 1:20 PM ET and replay access for 90 days. It reinforces ongoing investor outreach alongside existing disclosures on Q3 2025 performance and capital returns. Investors may focus on any incremental details shared about VITAS and Roto-Rooter, monitoring subsequent SEC filings and earnings updates for more concrete financial and operational information.
Key Terms
webcast technical
forward-looking statements regulatory
AI-generated analysis. Not financial advice.
CINCINNATI, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) today announced that it will present at the BofA Securities 2025 Virtual Home Care Conference on Tuesday, December 9, 2025, at 1:20 PM (ET).
The presentation will be webcast live and can be accessed, along with the presentation materials, through the Chemed website at www.chemed.com (Investor Relations). The webcast replay will be available within 24 hours of the live presentation and will be accessible for 90 days.
Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is the nation's largest provider of end-of-life hospice care and Roto-Rooter is the nation’s leading provider of plumbing and drain cleaning services.
Statements in this press release or in other Chemed communications may relate to future events or Chemed's future performance. Such statements are forward-looking statements and are based on present information Chemed has related to its existing business circumstances. Investors are cautioned that such forward-looking statements are subject to inherent risk that actual results may differ materially from such forward-looking statements. Further, investors are cautioned that Chemed does not assume any obligation to update forward-looking statements based on unanticipated events or changed expectations.
CONTACT: Michael D. Witzeman
(513) 762-6714